Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol TNNI3K contributors: mct - updated : 30-08-2010
HGNC name TNNI3 interacting kinase
HGNC id 19661
Location 1p31.1      Physical location : 74.663.946 - 75.010.108
Synonym name cardiac ankyrin repeat kinase
Synonym symbol(s) CARK
DNA
TYPE functioning gene
STRUCTURE 346.22 kb     25 Exon(s)
regulatory sequence Promoter
Binding site
text structure
  • MEF2 binding region is the most critical cis-acting element in the promoter, and TNNI3K transcription level can be down-regulated by MEF2C antisense (Wang 2008)
  • MAPPING cloned Y linked N status provisional
    RNA
    TRANSCRIPTS type messenger
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    25 - 3001 92.9 835 - Feng (2007)
    - - 3269 - 936 - Feng (2007)
    EXPRESSION
    Type
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Cardiovascularheart   highly
    Reproductivemale systemtestis   
    Urinarykidney    
    tissue
    SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
    Connectivebone   
    cell lineage
    cell lines
    fluid/secretion
    at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • seven N-terminal ankyrin (ANK) repeats, necessary for autophosphorylation
  • a protein kinase domain
  • a C-terminal Ser-rich domain, functional region that negatively regulates the kinase activity (Feng 2007)
  • HOMOLOGY
    Homologene
    FAMILY
    CATEGORY regulatory
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm
    intracellular,nucleus
    text in the nucleus of cardiac myocytes
    basic FUNCTION
  • cardiac-specific kinase playing an important role in cardiac system
  • exhibits dual-specific kinase activity and forms dimers or oligomers that may be necessary for its activation (Feng 2007)
  • improved cardiac function by enhancing beating frequency and increasing the contractile force and epinephrine response of spontaneous action potentials without an increase of the single-cell size (Lai 2008)
  • promotes cardiomyogenesis, enhances cardiac performance, and protects the myocardium from ischemic injury by suppressing p38/JNK-mediated apoptosis (Lai 2008)
  • may be involved in the development of cardiac hypertrophy (Lai 2009)
  • plays a critical role in the modulation of different forms of heart disease, and this protein may provide a novel target for therapeutic intervention (Wheeler 2009)
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • interacting with cardiac troponin I
  • interaction between TNNI3K and PRDX3 (Feng 2007)
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional     --over  
    may promote cardiac myogenesis, improve cardiac performance, and attenuate ischemia-induced ventricular remodeling (Lai 2009)
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
  • modulation of TNNI3K activity would be a useful therapeutic approach for ischemic cardiac disease (Lai 2008)
  • ANIMAL & CELL MODELS